# Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment

> **NCT01666431** · PHASE2 · TERMINATED · sponsor: **University of Zurich** · enrollment: 10 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Lapatinib

## Key facts

- **NCT ID:** NCT01666431
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666431, "Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01666431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*